Department of;Urology,;University College;Hospitals,;London NW1;2BU,;UKVIP亚洲男性学杂志(英文版)Borley N, Feneley MR. Prostate cancer: diagnosis and staging [J]. Asian J Androl, 2009, 11: 74-80.Borley N, Feneley MR. Prostate cancer: diagnosis and staging. Asian J Androl. Jan 2009;11(...
Two initial tests are commonly used to look forprostate cancerin the absence of any symptoms. One is thedigital rectal exam, in which a doctor feels the prostate through the rectum to find hard or lumpy areas known as nodules. The other is abloodtest used to detect a substance made by t...
For prostate cancer incidence, the endpoint was first diagnosis of prostate cancer (International Classification of Diseases Tenth revision codes: C6117) or death from prostate cancer (prostate cancer mentioned on the death certificate), whichever was first. Men were followed-up for cancer incidence u...
In recent years, evidence has accrued to support the introduction of multiparametric magnetic resonance imaging (mpMRI) in the prostate cancer diagnostic pathway. The exact role of mpMRI in different settings is not widely agreed. In this review, we look
Prostate cancer, disease characterized by uncontrolled growth of cells within the prostate gland. Prostate cancer is a frequently diagnosed cancer among males. Learn more about the causes, symptoms, and treatment of prostate cancer.
UK Sets the Pace in Prostate Cancer Fight; Scientists Bring Good News in Battles against Two of Our Biggest Killers There is growing recognition of the importance of the primary care physician in decision-making, diagnosis and management of patients with prostate cancer... D Mail 被引量: 0发表...
Current data shows only half (53%) of men with prostate cancer get an earlier diagnosis, which falls significantly short of the NHS's target of 75%. Black men have double the risk of both getting prostate cancer and dying from the disease, while men living in deprived areas of the U.K...
CBD capable of blocking metastasis in aggressive cancer Sugar in fruit juice as bad for you as in soft drinks Patients need personal plans after cancer diagnosis Off-label Niclosamide and research with prostate cancer Lutetium-177 PSMA therapy kills metastastic prostate cancer cells Prostate in-home...
Fig. 2: Cancer detection rate for csPCa. Forest plot representing relative CDR of MRI-GB to TRUS-GB. Full size image Does MRI-GB result in a lower CDR for insignificant PCa compared with TRUS-GB? MRI-GB was less likely to result in a diagnosis of clinically insignificant PCa. The diagn...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th